Indiana-based Biologics Modular has announced a significant milestone with respect to intellectual property for modular cleanroom technology. The Patent award encompasses the area where cleanroom modules are preassembled with air filtration systems already in place. Therefore when transported to the customer, it arrives as a pretested system, whether it is one unit or a cleanroom made up of multiple units connected together.
Biologics Modular designs and manufactures modular cleanroom facilities, delivered in an inter-modal container platform. With its flexible, scalable, and transportable modular construction, Biologics can guarantee minimised capital cost and shorter production timelines for its clients.
"From the beginning, we recognised the importance of developing and protecting our modular cleanroom technology," said Clark Byrum, President & CEO of Biologics Modular. "As a pioneer in the modular cleanroom industry, we knew our creativity would be recognised by patent officials. The issuance of this patent validates our product development and delivery along with a reiteration of Biologics Modular's commitment to our Customers, Partners and Investors."
